Proinflammatory Interleukin-33 Induces Dichotomic Effects on Cell Proliferation in Normal Gastric Epithelium and Gastric Cancer

Abstract

Interleukin (IL)-33 is a member of the interleukin (IL)-1 family of cytokines linked to the development of inflammatory conditions and cancer in the gastrointestinal tract. This study is designed to investigate whether IL-33 has a direct effect on human gastric epithelial cells (GES-1), the human gastric adenocarcinoma cell line (AGS), and the gastric carcinoma cell line (NCI-N87) by assessing its role in the regulation of cell proliferation, migration, cell cycle, and apoptosis. Cell cycle regulation was also determined in ex vivo gastric cancer samples obtained during endoscopy and surgical procedures. Cell lines and tissue samples underwent stimulation with rhIL-33. Proliferation was assessed by XTT and CFSE assays, migration by wound healing assay, and apoptosis by caspase 3/7 activity assay and annexin V assay. Cell cycle was analyzed by means of propidium iodine assay, and gene expression regulation was assessed by RT-PCR profiling. We found that IL-33 has an antiproliferative and proapoptotic effect on cancer cell lines, and it can stimulate proliferation and reduce apoptosis in normal epithelial cell lines. These effects were also confirmed by the analysis of cell cycle gene expression, which showed a reduced expression of pro-proliferative genes in cancer cells, particularly in genes involved in G0/G1 and G2/M checkpoints. These results were confirmed by gene expression analysis on bioptic and surgical specimens. The aforementioned results indicate that IL-33 may be involved in cell proliferation in an environment- and cell-type-dependent manner.

Interleukin-33 as a Potential Therapeutic Target in Gastric Cancer Patients: Current Insights

“…In a contrasting study, using an in vitro model, Pisani et al showed that IL-33 might be involved in inducing antitumorigenic and antiproliferative effects on GC cells. 98 …”

Gastric alarmin release: A warning signal in the development of gastric mucosal diseases

“…Some researchers have shown that IL-33 can promote continuous GC cell growth by inducing the MC-dependent production and release of macrophage-attracting factors ( 27 ) or by activating the mitogen-activated protein kinase (MAPK) pathway, which includes extracellular signal-regulated kinases (ERKs) such as ERK1/2, JNK and p38 ( 70 , 71 ), thereby promoting GC proliferation, differentiation, migration and apoptosis ( 132 ). Interestingly, a recent study showed that IL-33 can inhibit cyclin C (CCNC, G0/G1 transition) and cyclin B1 (CCNB1, G2/M transition) and that cysteine aspartase-3 (CASP3) activation decreases tumor cell proliferation and thus may be involved in cell proliferation in an environment- and cell type-dependent manner ( 72 ). Therefore, IL-33 may be an immunotherapy target for preventing the progression of CG to early stage GC.…”

Exploring Lung Cancer Protein Network: Understanding Structure and Function through Metric Space Modeling

“…These networks have aided in identifying pivotal "hub proteins" like EGFR and TP53, known to play critical roles in tumorigenesis and disease progression [46]. Additionally, PPI networks have proven instrumental in discovering novel biomarkers for early diagnosis and improved patient prognosis [12] [24]. Furthermore, it is vital to identify crucial proteins through PPI analysis to gain a comprehensive understanding of cellular processes, disease mechanisms, and potential targets for therapeutic [7].…”